Ayuda
Ir al contenido

Dialnet


SEOM clinical guideline for the management of malignant melanoma (2017)

    1. [1] Hospital Universitario Virgen Macarena

      Hospital Universitario Virgen Macarena

      Sevilla, España

    2. [2] Hospital Universitario La Paz

      Hospital Universitario La Paz

      Madrid, España

    3. [3] Hospital Clínico San Carlos de Madrid

      Hospital Clínico San Carlos de Madrid

      Madrid, España

    4. [4] Hospital General Universitario Gregorio Marañón

      Hospital General Universitario Gregorio Marañón

      Madrid, España

    5. [5] Hospital Ramón y Cajal

      Hospital Ramón y Cajal

      Madrid, España

    6. [6] Clínica Universitaria de Navarra

      Clínica Universitaria de Navarra

      Pamplona, España

    7. [7] Hospital General Universitario de Valencia

      Hospital General Universitario de Valencia

      Valencia, España

    8. [8] Hospital Clinic i Provincial de Barcelona, España
    9. [9] Hospital Torrecárdenas, España
    10. [10] Hospital Universitario Quirón Dexeus, España
  • Localización: Clinical & translational oncology, ISSN 1699-048X, Vol. 20, Nº. 1 (January 2018), 2018, págs. 69-74
  • Idioma: inglés
  • Texto completo no disponible (Saber más ...)
  • Resumen
    • All melanoma suspected patients must be confirmed histologically and resected. Sentinel node biopsy must be done when tumor is over 1 mm or if less with high-risk factors. Adjuvant therapy with interferon could be offered for patients with high-risk melanoma and in selected cases radiotherapy can be added. Metastatic melanoma treatment is guided by mutational BRAF status. BRAF wild type patients must receive anti-PD1 containing therapy and BRAF mutated patients BRAF/MEK inhibitors or anti-PD1 containing therapy. Up to 10 years follow up is reasonable for melanoma patients with dermatologic examinations and physical exams.


Fundación Dialnet

Dialnet Plus

  • Más información sobre Dialnet Plus

Opciones de compartir

Opciones de entorno